T1	Disorder 10 34	Stevens-Johnson syndrome
N1 	Reference T1 UMLS:C0038325	Stevens-Johnson syndrome
T2	Pharmacological_substance 49 68	antiretroviral drug
N1000 	Reference T2 MeSH:D044966	antiretroviral drug
T3	Pharmacological_substance 69 79	nevirapine
N1001 	Reference T3 MeSH:D019829	nevirapine
T4	Pharmacological_substance 82 92	Nevirapine
N1002 	Reference T4 MeSH:D019829	Nevirapine
T7	Pharmacological_substance 183 204	antiretroviral agents
N1003 	Reference T7 MeSH:D044966	antiretroviral agents
T8	Disorder 226 239	HIV infection
N2 	Reference T8 UMLS:C0019693	HIV infection
N3 	Reference T8 UMLS:C0019693	HIV infection
T9	Disorder 268 292	Stevens-Johnson syndrome
N4 	Reference T9 UMLS:C0038325	Stevens-Johnson syndrome
T10	Disorder 294 297	SJS
N5 	Reference T10 UMLS:C0038325	SJS
T12	Pharmacological_substance 325 335	nevirapine
N1004 	Reference T12 MeSH:D019829	nevirapine
T13	Pharmacological_substance 538 548	nevirapine
N1005 	Reference T13 MeSH:D019829	nevirapine
T14	Disorder 560 563	SJS
N6 	Reference T14 UMLS:C0038325	SJS
T15	Disorder 638 641	SJS
N7 	Reference T15 UMLS:C0038325	SJS
T16	Pharmacological_substance 653 663	nevirapine
N1006 	Reference T16 MeSH:D019829	nevirapine
T18	Combination 160 171	combination
T19	Disorder 248 252	rash
N8 	Reference T19 UMLS:C0015230	rash
T25	Subject 458 466	patients
T26	Disorder 472 475	HIV
N9 	Reference T26 UMLS:C3854222	HIV
T27	Disorder 499 511	complication
N10 	Reference T27 UMLS:C0009566	complication
T5	Manner_cue 241 247	Severe
